Alaunos Therapeutics, Inc. (TCRT)

NASDAQ: TCRT · USD

$2.11

+0.05 (+2.4%)· Recorded snapshot

Market cap	5.4M
Revenue (ttm)	3K
Net income (ttm)	-4.1M
EPS (ttm)	-$1.77
Shares out	2.5M
Volume	583,630
Beta	-0.87

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 3K
Net income (ttm): -4.1M
EPS (ttm): -$1.77
Market cap: 5.4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	احتفاظ

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-185.9

P25 n/aP50 n/aP75 n/a

ROIC-117.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TCRT indicators

Market & fundamental data

Available fields

202

Groups with data

Currency

USD

Showing 202 of 202 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001107421
Company name	Alaunos Therapeutics, Inc.
Country	United States
Country code	US
CUSIP number	98973P309
Earnings date	2026-11-13
Earnings time	amc
Employees	1
Employees change	-33
Employees growth	-97.06%
Enterprise value	$5.2M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1998
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US98973P3091
Last 10-K release date	2026-03-31
Last earnings date	2026-08-14
Last refreshed	2026-10-28
Last stock split date	2024-07-18
Last stock split type	Reverse
Market cap	$5.4M
Market cap category	Nano-Cap
Next earnings date	2026-11-13
Options	No
Price	$2.11
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	TCRT
U.S. state	Florida
Website	https://www.alaunos.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-83.81%
EV/Sales	1,728.53x
FCF / EV yield	-54.48%
FCF yield	-53.21%
P/B ratio	7.86x
P/S ratio	1,769.87x
Price / tangible book value	8.14x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Operating margin	-135,233.33%
Pretax margin	-133,666.67%
Profit per employee	$-4.1M
Revenue per employee	$3,000
ROA	-81.13%
ROA (5Y)	-51.82%
ROCE	-622.24%
ROE	-185.95%
ROE (5Y)	-126.24%
ROIC	-117.58%
SBC / revenue	18,333.33%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	19
EPS growth years	6
Net income growth quarters	2
Net income growth years	6
Revenue growth	-50%
Revenue growth 10Y	-54.24%
Revenue growth 3Y	-89.92%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-98,000
Depreciation and amortization	$23,000
EBIT	$-4.1M
EBITDA	$-4M
EPS	$-1.77
FCF per share	$-1.11
Financing cash flow	$70,000
Free cash flow	$-2.8M
Free cash flow minus SBC	$-3.4M
Gross profit	$-1.6M
Investing cash flow	$-98,000
Net borrowing	$70,000
Net cash flow	$-2.8M
Net income	$-4.1M
Operating cash flow minus SBC	$-3.3M
Operating income	$-4.1M
Revenue	$3,000
Stock-based compensation	$550,000

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-860.17
Book value per share	$0.26
Debt / equity	0
Long-term assets	$850,000
Long-term liabilities	$0
Net cash (debt)	$124,000
Net cash / market cap	2.34%
Net cash growth	-95.69%
Net debt / equity	-0.19
Piotroski F-Score	1
Property, plant and equipment	$74,000
Shareholders' equity	$652,000
Tangible book value	$652,000
Tangible book value per share	$0.26
Total assets	$1.5M
Total cash	$124,000
Total debt	$0
Total liabilities	$864,000
WACC	-0.53%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0
Current assets	$666,000
Current liabilities	$864,000
Current ratio	0.77
Net working capital	$-322,000
Quick ratio	0.14
Working capital	$-198,000
Working capital turnover	0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-43.66%
Dividend yield	0%
Shareholder yield	-43.66%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-99.74%
10Y return CAGR	-44.9%
10Y total return	-99.74%
150-day SMA	$2.13
15Y price change	-99.71%
15Y return CAGR	-32.21%
15Y total return	-99.71%
1D price change	2.43%
1M price change	93.58%
1M total return	93.58%
1W price change	-31.49%
1W total return	-31.49%
1Y price change	-26.99%
1Y return CAGR	-27.01%
1Y total return	-26.99%
20-day SMA	$1.87
200-day SMA	$2.34
20Y price change	-99.73%
20Y return CAGR	-25.63%
20Y total return	-99.73%
3M price change	9.33%
3M total return	9.33%
3Y price change	-84.19%
3Y return CAGR	-45.93%
3Y total return	-84.19%
50-day SMA	$1.63
50-day SMA vs 200-day SMA	50under200
52-week high	$4.50
52-week high date	2025-12-12
52-week low	$0.72
52-week low date	2026-10-06
5Y price change	-99.04%
5Y return CAGR	-60.49%
5Y total return	-99.04%
6M price change	-21.85%
6M total return	-21.85%
All-time high	$2,239.50
All-time high date	2015-11-10
All-time low	$0.72
All-time low date	2026-10-06
Average true range (ATR)	$0.50
Average volume	21.5M
Beta (1Y)	-2.82
Beta (2Y)	-3.01
Beta (5Y)	-0.87
Change from 52-week high	-53.11%
Change from 52-week low	193.46%
Change from all-time high	-99.91%
Change from all-time low	193.46%
Change from open	-2.31%
Day's gap	4.85%
Dollar volume	$1.2M
High price	$2.16
Low price	$2.01
Monthly RSI	37.4
Open price	$2.16
Position in 52-week range	66.67%
Premarket change	5.83%
Premarket close	$2.06
Premarket price	$2.18
Premarket volume	210.6K
Previous close	$2.06
Price vs 150-day SMA	-0.99%
Price vs 20-day SMA	12.71%
Price vs 200-day SMA	-9.83%
Price vs 50-day SMA	29.13%
Relative volume	0.03
RSI	52.47
Sharpe ratio	0.46
Sharpe ratio (3Y)	0.21
Sharpe ratio (5Y)	0.01
Sortino ratio	1.45
Sortino ratio (3Y)	0.5
Sortino ratio (5Y)	0.07
Volume	583.6K
Weekly RSI	51.55
YTD price change	-34.67%
YTD total return	-34.67%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.2M
Float percentage	47.38%
Shares change (QoQ)	24.81%
Shares change (YoY)	43.66%
Shares held by insiders	25.55%
Shares held by institutions	6.01%
Shares outstanding	2.5M
Short % of float	0.81%
Short % of shares	0.38%

Deeper analysis on TCRT

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TCRT report

Is a complete TCRT research report available?

No complete published report is available for Alaunos Therapeutics, Inc. (TCRT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Alaunos Therapeutics, Inc. (TCRT)

Price

Financial snapshot

Fair-value bridge

Latest news · TCRT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TCRT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TCRT

Frequently asked questions